Chi-Ming Chow | |
---|---|
Nationality | Canadian |
Alma mater | McGill University, Montréal, Québec |
Occupation(s) | Cardiologist, St. Michael's Hospital Board of Directors, Heart and Stroke Foundation of Ontario |
Chi-Ming Chow is a Canadian cardiologist at St. Michael's Hospital in Toronto, Ontario, Canada. He is often interviewed on national media about issues involving cardiovascular health, [1] [2] [3] [4] [5] and is regarded as an influential advocate for heart health in the Canadian Chinese community. [6]
Chow is an attending staff cardiologist at St. Michael's Hospital, Toronto, Ontario, Canada. He is also a Professor [7] in the Department of Medicine, University of Toronto. He has an undergraduate degree in computer science from Brown University, Providence, Rhode Island, USA. He completed his Doctor of Medicine degree in 1990 at McGill University, in Montréal, Québec and a Masters of Science in Epidemiology, also at McGill University, in 1997. He completed his residency training in family medicine, internal medicine and cardiology at McGill University. He then pursued a clinical and research echocardiography fellowship at the Massachusetts General Hospital, Boston, Massachusetts, USA.
He had won multiple local and national teaching awards to recognize his teaching and innovation in medical education. He is a winner of the Ruedy Award for Innovation in Medical Education presented by the Association of Faculties of Medicine of Canada and Dalhousie University Faculty of Medicine [8] and the 2009 William Goldie Prize for Innovation by the Department of Medicine, University of Toronto.
He is currently a board member and media spokesperson for the Heart and Stroke Foundation of Ontario. To recognize his service to the Heart and Stroke Foundation of Ontario, he won the Award For Volunteer Excellence in 2007 and the Rick Gallop Award for Pioneering Leadership in 2008.
He participates actively in health promotion and research among ethnic Chinese in Canada. He was awarded the Best Community Service Award by the Association of Chinese Canadian Entrepreneurs in 2010. [9]
Chow created a number of software packages for smartphones, including CardioMath (a calculator for commonly used formulas in cardiovascular medicine cardiology) [10] [11]
The University of Ottawa Heart Institute (UOHI) (French: Institut de cardiologie de l'Université d'Ottawa ) is Canada's largest cardiovascular health centre. It is located in Ottawa, Ontario, Canada. It began as a department in The Ottawa Hospital, and since has evolved into a complete cardiac centre, encompassing prevention, diagnosis, treatment, rehabilitation, research, and education.
Sir Magdi Habib Yacoub is an Egyptian-British retired professor of cardiothoracic surgery at Imperial College London, best known for his early work in repairing heart valves with surgeon Donald Ross, adapting the Ross procedure, where the diseased aortic valve is replaced with the person's own pulmonary valve, devising the arterial switch operation (ASO) in transposition of the great arteries, and establishing the heart transplantation centre at Harefield Hospital in 1980 with a heart transplant for Derrick Morris, who at the time of his death was Europe's longest-surviving heart transplant recipient. Yacoub subsequently performed the UK's first combined heart and lung transplant in 1983.
Sudarshan (Sudi) Devanesen, CM, is a family medicine physician and educator, public health activist, and member of the Order of Canada. He is known for his role in preventing heart disease in Canadian South Asians.
Hypertensive heart disease includes a number of complications of high blood pressure that affect the heart. While there are several definitions of hypertensive heart disease in the medical literature, the term is most widely used in the context of the International Classification of Diseases (ICD) coding categories. The definition includes heart failure and other cardiac complications of hypertension when a causal relationship between the heart disease and hypertension is stated or implied on the death certificate. In 2013 hypertensive heart disease resulted in 1.07 million deaths as compared with 630,000 deaths in 1990.
Pierre Grondin was a Canadian cardiac surgeon who was one of the first doctors to perform a successful heart transplant. He brought many innovations to the Montreal Heart Institute after his post-graduate training with pioneers Michael DeBakey and Denton Cooley in Houston, Texas. He was one of a select few heart surgeons worldwide who participated in the development of open-heart surgery using the heart-lung machine in the early 1950s. He performed the first successful heart transplantation in Canada at the Montreal Heart Institute in May 1968.
Celacade was a non-drug, device-based treatment also known as Immune Modulation Therapy (IMT), developed by the Canadian-based biotherapeutics company Vasogen, Inc. for chronic heart failure and peripheral artery disease. Blood was piped through the device, where it was exposed to heat, ultraviolet light, and ozone, in the hope that this oxidative stress would trigger an anti-inflammatory immunomodulation response.
Adolfo José de Bold was an Argentine-born Canadian cardiovascular researcher, best known for his discovery of atrial natriuretic peptide (ANP), a polypeptide hormone secreted by heart muscle cells. The hormone plays a role in regulating blood pressure, blood volume, and cardiovascular growth, and its discovery proved the endocrine function of the heart.
Lucien Campeau was a Canadian cardiologist. He was a full professor at the Université de Montréal. He is best known for performing the world's first transradial coronary angiogram. Campeau was one of the founding staff of the Montreal Heart Institute, joining in 1957. He is also well known for developing the Canadian Cardiovascular Society grading of angina pectoris.
Dr Purshotam Lal is an Indian Interventional cardiologist who has to his credit the pioneering of over 20 interventional cardiology procedures for the first time in India, some of which were the first time in the World. Trained in UK, US and Germany, and he has held various faculty positions including Professor, Advisor, etc.
Paul Dorian is a Canadian physician. He is a professor of pharmacology and director of the Division of Cardiology at the University of Toronto. His primary research focus is the clinical pharmacology of antiarrhythmic drugs.
Jean-Claude Tardif is the Director of the Research Center at the Montreal Heart Institute and Professor of Medicine at the University of Montreal. He received his medical degree (MD) in 1987 from the University of Montreal and specialized in cardiology and research in Montreal and Boston until 1994. Dr. Tardif holds the Canada Research Chair in personalized medicine and the University of Montreal endowed research chair in atherosclerosis. He is also the Scientific Director of the Montreal Health Innovations Coordinating Center (MHICC).
Park Seung-jung is a South Korean cardiologist. Currently he is chairman of the Heart Institute at Asan Medical Center in Seoul and professor of medicine at University of Ulsan.
Yaariv Khaykin is a Canadian cardiologist and a clinical researcher in the area of electrophysiology. He is the director of the Newmarket Electrophysiology Research Group at the Southlake Regional Health Centre. He has published research into complex ablation and pioneered cardiac ablation methods.
Ulf Landmesser is a German specialist for cardiology and internal medicine. He is professor at the Institute for Health Research in Berlin and Head of the Medical Clinic of Cardiology at the Charité in Berlin. Landmesser is known for his work on coronary interventions and modern methods of catheter-based heart valve therapy.
Donald S. Baim was a researcher and clinician in the field of interventional cardiology. Baim's primary research focused on coronary blood flow, catheter intervention in heart disease, and congestive heart failure. His work helped to shift the use of catheters from a purely diagnostic tool to a therapeutic tool. After receiving a medical degree from Yale and initial medical training, residency and a fellowship at Stanford University Medical Center, Baim spent the bulk of his career at Beth Israel Hospital and at the Brigham and Women's Hospital in Boston. In 1993, Baim founded the Beth Israel Hospital's Cardiovascular Data Analysis Center (CDAC) -- later to be named Harvard Clinical Research Institute (HCRI). Baim died of cancer in November 2009. In October 2016, HCRI changed its name to the Baim Institute for Clinical Research.
Rhian M. Touyz Koppel is a Canadian medical researcher. She is currently serving as the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre in Montreal, Canada, since 2021. A clinician scientist, her research primarily focuses on hypertension and cardiovascular disease.
The Louis and Artur Lucian Award in Cardiovascular Diseases is a prize for cardiovascular medicine conferred by McGill University. Described as Canada's "top cardiovascular research prize", it has been awarded annually since 1978, except in 2007.
Martha Gulati is the past Chief of Cardiology at the University of Arizona, Phoenix. She previously held the Sarah Ross Soter Chair in Women’s Cardiovascular Health at the Ohio State University. Gulati is the Chair of the National Chest Pain Guidelines. She is the author of the popular science book Saving Women’s Heart and Editor-in-Chief of materials for the American College of Cardiology programme CardioSmart.
Ruth L. Collins-Nakai is a retired Canadian cardiologist, educator, researcher, physician leader, healthcare advisor, and public health advocate.
Clara Chow is an Australian cardiologist who is the program director of community-based cardiac services at Sydney's Westmead Hospital. She is a professor of medicine at the University of Sydney in the field of cardiovascular disease epidemiology, prevention, treatment and innovation. In 2019, she was appointed the academic director of the Westmead Applied Research Centre, a collaborative centre with a mission to better understand the causes of cardiovascular disease and translate their research to new treatments. She has also held the role of academic co-director of the Charles Perkins Centre since 2016.